Home
Welcome to Borman and Company
Borman & Company Welcomes Lipoi Finau
Written by BACO News Release   

Borman & Company welcomes Lipoi Finau to our team.  Lipoi specializes in the financial and administrative management of complex not-for-profit organizations.  His work has served as the foundation for financial workflow improvement, eliminating needless processes, and instituting effective risk management and audit practices.  He is an acknowledged expert in sponsored research management administration and compliance.

Mr. Finau has worked at Harvard University as the Director of Finance and Accounting as well as the Technical Education Research Center as their Controller.
Last Updated on Wednesday, 14 December 2011 06:11
 

Latest News

Focus on Life Sciences

  • The Burrill Report (January 30, 2012): What's Driving Roche's $5.7 Billion Bid for Illumina
    Roche’s $5.7 billion hostile bid for the sequencing company Illumina could create a personalized medicine powerhouse capable of not only driving a transformation in the treatment of disease, but its diagnosis as well. Roche has big visions, but the deal has raised some eyebrows. We spoke to Chris Bowe, U.S. Healthcare analyst for Scrip about Roche’s efforts, what it means for personalized medicine, and what some other M&A activity tells us about the industry's changing landscape.

Focus on Global Trade

  • CBP Adopts Changes to Country of Origin Rules Applicable to Certain Commodities
    Customs and Border Protection (CBP) posted a final rule in the Federal Register amending the country of origin rules applicable to pipe fittings and flanges, greeting cards, glass optical fiber, rice preparations, and certain textile and apparel products, as codified in part 102 of the CBP regulations. ... The tariff shift rule in CBP regulations has been amended for commodities classified in headings 7301 through 7307, HTSUS, and now provides for a change within heading 7307 from fitting forgings or...